Pharmaceutical Executive
The importance of betting on outcomes, not simply risk sharing, when implementing pharma-payer arrangements. .
Urs Wiedemann
Advertisement
Articles by Urs Wiedemann
Advertisement
Latest Updated Articles
Raising the Stakes On Value-Based PricingApril 12th 2016
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Onswik for Adults with Type 2 Diabetes
2
What Actually Went Wrong When a Phase 3 Trial Fails: Q&A with Dr. Remo Moomiaie-Qajar
3
The Legacy of Rutledge: How States and Congress Can Still Regulate Pharmacy Benefit Managers
4
Novartis & BoomRay Enter Global License Agreement for Preclinical Radioligand Asset
5